Literature DB >> 23718561

Expression of oral cytokines in HIV-infected subjects with long-term use of antiretroviral therapy.

W Nittayananta1, K Amornthatree, M Kemapunmanus, S Talungchit, H Sriplung.   

Abstract

OBJECTIVES: The objectives of this study were to determine (i) the expression of oral pro-inflammatory cytokines in HIV-infected subjects compared with non-HIV individuals, (ii) the cytokine expression in the subjects with antiretroviral therapy (ART) compared with those without ART, and (iii) factors associated with the expression of the cytokines.
MATERIALS AND METHODS: Oral examination was performed and saliva samples were collected and analyzed for the expression of pro-inflammatory cytokines using ELISA. Logistic regression analysis was performed to determine the association between HIV/ART status and the cytokine expression.
RESULTS: One hundred and fifty-seven HIV-infected subjects with and without ART, and 50 non-HIV individuals were enrolled. TNF-α and IL-6 in saliva were significantly decreased, while IL-8 was significantly increased in HIV infection (P < 0.05). Changes in the expression of IL-8 were also observed between HIV-infected subjects who were and were not on ART (P < 0.05). Duration of HIV infection and smoking was significantly associated with the expression of pro-inflammatory cytokines in saliva (P < 0.05).
CONCLUSION: Oral innate immunity is affected by HIV infection and use of ART. IL-8 may be the useful biomarker to identify subjects at risk of infection and malignant transformation due to HIV infection and long-term use of ART.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ART; HIV; antiretroviral therapy; cytokines; pro-inflammatory cytokines; saliva

Mesh:

Substances:

Year:  2013        PMID: 23718561      PMCID: PMC3859523          DOI: 10.1111/odi.12135

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  33 in total

Review 1.  The host cytokine responses and protective immunity in oropharyngeal candidiasis.

Authors:  A Dongari-Bagtzoglou; P L Fidel
Journal:  J Dent Res       Date:  2005-11       Impact factor: 6.116

2.  Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.

Authors:  J Mork; A K Lie; E Glattre; G Hallmans; E Jellum; P Koskela; B Møller; E Pukkala; J T Schiller; L Youngman; M Lehtinen; J Dillner
Journal:  N Engl J Med       Date:  2001-04-12       Impact factor: 91.245

Review 3.  Oral mucosal immunity and HIV infection: current status.

Authors:  S J Challacombe; S P Sweet
Journal:  Oral Dis       Date:  2002       Impact factor: 3.511

4.  Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.

Authors:  Rolando Herrero; Xavier Castellsagué; Michael Pawlita; Jolanta Lissowska; Frank Kee; Prabda Balaram; Thangarajan Rajkumar; Hema Sridhar; Barbara Rose; Javier Pintos; Leticia Fernández; Ali Idris; María José Sánchez; Adoración Nieto; Renato Talamini; Alessandra Tavani; F Xavier Bosch; Ulrich Reidel; Peter J F Snijders; Chris J L M Meijer; Raphael Viscidi; Nubia Muñoz; Silvia Franceschi
Journal:  J Natl Cancer Inst       Date:  2003-12-03       Impact factor: 13.506

5.  Classification and diagnostic criteria for oral lesions in HIV infection. EC-Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency Virus.

Authors: 
Journal:  J Oral Pathol Med       Date:  1993-08       Impact factor: 4.253

6.  IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva.

Authors:  S P Sweet; D Rahman; S J Challacombe
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

7.  Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.

Authors:  J Lähdevirta; C P Maury; A M Teppo; H Repo
Journal:  Am J Med       Date:  1988-09       Impact factor: 4.965

8.  Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy.

Authors:  L L Patton; R McKaig; R Strauss; D Rogers; J J Eron
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2000-03

9.  Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS.

Authors:  M Glick; B C Muzyka; D Lurie; L M Salkin
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1994-04

10.  Oral signs and symptoms in 160 Greek HIV-infected patients.

Authors:  G Laskaris; M Hadjivassiliou; J Stratigos
Journal:  J Oral Pathol Med       Date:  1992-03       Impact factor: 4.253

View more
  6 in total

Review 1.  Current trends and new developments in HIV research and periodontal diseases.

Authors:  Mark I Ryder; Caroline Shiboski; Tzy-Jyun Yao; Anna-Barbara Moscicki
Journal:  Periodontol 2000       Date:  2020-02       Impact factor: 7.589

2.  Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers.

Authors:  Gregory H Taylor; Adrienne A Williams; Alfredo Garzino-Demo
Journal:  Pathog Dis       Date:  2015-12-09       Impact factor: 3.166

3.  Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.

Authors:  Medini K Annavajhala; Sabrina D Khan; Sean B Sullivan; Jayesh Shah; Lauren Pass; Karolina Kister; Heather Kunen; Victor Chiang; Gwennaëlle C Monnot; Christopher L Ricupero; Rebecca A Mazur; Peter Gordon; Annemieke de Jong; Sunil Wadhwa; Michael T Yin; Ryan T Demmer; Anne-Catrin Uhlemann
Journal:  mSphere       Date:  2020-02-05       Impact factor: 4.389

4.  Long Term Delta-9-tetrahydrocannabinol Administration Inhibits Proinflammatory Responses in Minor Salivary Glands of Chronically Simian Immunodeficieny Virus Infected Rhesus Macaques.

Authors:  Xavier Alvarez; Karol Sestak; Siddappa N Byrareddy; Mahesh Mohan
Journal:  Viruses       Date:  2020-07-01       Impact factor: 5.818

5.  Oral Cytokine Levels Are More Linked to Levels of Plasma and Oral HIV-1 RNA Than to CD4+ T-Cell Counts in People With HIV.

Authors:  Joseph M Rocco; Zachary York; Chengli Shen; Caroline Shiboski; Jennifer Cyriaque-Webster; Janet McLaughlin; Luann Borowski; Huichao Chen; Judith A Aberg; Dirk P Dittmer; Mahmoud Ghannoum; Charles R Rinaldo; Bernard Macatangay
Journal:  Open Forum Infect Dis       Date:  2020-02-13       Impact factor: 3.835

6.  Stage II and stage III periodontitis clinical burdens of HIV-1 undergoing antiretroviral therapy.

Authors:  Lucio Souza Gonçalves; Dennis de Carvalho Ferreira; Fabio Vidal; Rodrigo Carvalho Souza; Cristiane Gonçalves; Priscila Pavan; Florence Carrouel; Denis Bourgeois; Gregory J Seymour
Journal:  Clin Oral Investig       Date:  2021-10-03       Impact factor: 3.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.